Hidradenitis suppurativa (HS) remains one of dermatology's most commonly misdiagnosed conditions, with patients often waiting years before receiving accurate identification. HS is a chronic inflammatory skin disease that produces painful, boil-like lumps primarily in friction-prone areas like the armpits, groin, and under the breasts. Unlike temporary skin infections, HS creates interconnected tracts beneath the skin surface that require long-term management.
Seven conditions frequently masquerade as HS, delaying proper treatment. Acne vulgaris tops the list because both conditions produce pustules and nodules. However, acne responds to standard treatments while HS does not. Cysts, ingrown hairs, and folliculitis present similar surface symptoms but lack HS's characteristic sinus tracts and recurrent nature. Boils and abscesses appear identical initially but resolve independently, whereas HS persists without intervention. Herpes simplex virus infection rounds out the common misdiagnoses because the vesicular rash can occur in genital areas where HS frequently develops.
The consequences of misdiagnosis extend beyond inconvenience. Patients receive antibiotics that fail to address the underlying inflammation. They endure unnecessary topical treatments designed for acne or temporary infections. This delays evidence-based HS care, which typically involves biologic medications, retinoids, or surgical intervention depending on severity. During these lost years, HS often progresses to more advanced stages, creating deeper tissue involvement and scarring.
Dermatologists experienced in HS recognize distinctive patterns that set it apart. The condition typically appears during late adolescence or early adulthood. Lesions tend to recur in identical locations across multiple flare cycles. Patients report significant pain beyond what surface inspection suggests. Drainage of purulent material persists between flares.
Seeking